Results

Total Results: 1,524 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_executive.pdf
    September 19, 2014 - dosing, application of dose thresholds), concomitant therapies (e.g., use of benzodiazepines or other drugs … Strategy (REMS) a single shared system - Current Application Holders. http://www.fda.gov/ downloads/Drugs … Available at:http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-updates_methods.pdf
    July 01, 2011 - evidence-based-policy- center/derp/index.cfm), has conducted SRs of comparative effectiveness and safety for drugs … then key questions for potential modifications are assessed to accommodate new evidence (e.g., new drugs … These developments include new controversies, drugs or devices in development, ongoing trials and … across EPCs across the range of health care interventions and treatment modalities (e.g., devices, pharmaceuticalproducts, surgery, diagnostic tests, and other procedures) is needed.
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children-future_research.pdf
    February 01, 2012 - For the majority of antipsychotic drugs, approved indications in the United States are restricted to … and becomes notably more resource intensive for the comparison of three or more drugs. … Second- generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. … Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review … None named Novartis Pharmaceuticals NCT01256177 Evaluate the Efficacy and Safety of Quetiapine Fumarate
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/head-neck-cancer-update_consumer.pdf
    August 01, 2015 - � Chemotherapy: Certain drugs are used to kill cancer cells.
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
    August 01, 2020 - for the same drug, while Table 5b summarizes retention findings for XR and daily formulations for drugs … vulnerability assessment for rapid dissemination of HIV or HCV infections among persons who inject drugs … KQ3: Not reported Fair Rosenthal, 201634 RCT USA Braeburn Pharmaceuticals 177 Age … Medications Timing & Outcome Interventions Results Quality Rating Lofwall, 201835 RCT USA Braeburn Pharmaceuticals
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-childhood-protocol.pdf
    August 06, 2018 - Pharmacological agents used to treat child and adolescent depression Class Drugs Selective serotonin … Tricyclic drugs for depression in children and adolescents. … 7-25-18 1st addendum database - CINAHL done 7-27-18 2nd addendum in all indexes for rarely used drugs … antidepressive agents”[Title/Abstract] OR “antidepressive drug”[Title/Abstract] OR “antidepressive drugs … OR “antidepressive agent” OR “antidepressive agents” OR “antidepressive drug” OR “antidepressive drugs
  7. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … at Point of This Intervention Patients with OA are often prescribed nonsteroidal anti-inflammatory drugs
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/quantitative-synthesis-expanded-methods_methods.pdf
    March 01, 2013 - combined functional outcomes measured on different scales in placebo-controlled studies of Alzheimer’s drugs … and large referents,34 the clinical significance of the additional treatment effect of Alzheimer’s drugs … Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. … Drugs Aging. 2007;24:155-67. 34. Cohen J.
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
    January 01, 2007 - Survey of Medicare Part D Plans’ Medication Therapy Management Programs Effective Health Care Research Reports Number 1 Survey of Medicare Part D Plans’ Medication Therapy Management Programs Daniel R. Touchette, Pharm.D., M.A. Anne L. Burns, R.Ph. Marcie A. Bough, Pharm.D. Juan C. Blackburn, M.D., M.B.…
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_disposition-comments.pdf
    October 07, 2011 - the Food and Drug Administration and as described in the prescribing information for the above cited drugs … Prescribing information for these drugs may be obtained from www.astrazeneca-us.com or by calling the … Recommend the following language: “When used in pregnancy during the second and third trimesters, drugs
  11. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
    October 01, 2018 - Formulary Committee Neurology and Psychiatry Task Force, responsible for making decisions on which drugs … therapy (specifically, they were asked to simulate a decision in which they are trying to choose which drugs …  Explicit description of the intervention (dosing, duration, delivery, manpower, trade names of drugs
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/acute-pain-ems-protocol-amendment.pdf
    January 28, 2019 - analgesics, including ketamine, nitrous oxide/oxygen, acetaminophen, and non-steroidal anti-inflammatory drugs … prehospital analgesia, issues pertaining to emergency medical services (EMS) personnel who administer the drugs … Abbreviations: KQ=key question; NSAIDs=nonsteroidal anti-inflammatory drugs; PICOTS=population, intervention
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
    November 02, 2019 - Evidence-based Practice Center Systematic Review Protocol: Therapies for Clinically Localized Prostate Cancer Evidence-based Practice Center Systematic Review Protocol Project Title: Therapies for Clinically Localized Prostate Cancer Initial Publication Date: September 12, 2019 Amendment Date: November 2,…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-203-adhd-disposition-comments.pdf
    January 01, 2018 - Public Reviewer #4 (Manisha Madhoo, Shire Pharmaceuticals) (Previous row continued) Methods • … CNS Drugs. 2013 Dec;27(12):1081-92. … Public Reviewer #4 (Manisha Madhoo, Shire Pharmaceuticals) Methods Lastly, the authors may want … TEP Reviewer #2 Discussion/ Conclusion [conclusion that for ADHD treatment, FDA-approved drugs most … Yet the conclusions make clear recommendation that "For ADHD treatment, FDA-approved drugs are most
  15. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … It differentiated 100% of multiple drugs and doses taken simultaneously by type and by dose.
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
    October 01, 2017 - These reviews focus on a variety of issues, including assessing and comparing clinical drugs, treatments … I feel like the thing that I'm most struggling with from an evidence-based standpoint, is limiting pharmaceuticals … o What are the opportunities to substitute less costly, but equally effective, pharmaceuticals for specific … These reviews focus on a variety of issues, including comparing clinical drugs or treatments, and interventions … o Prevention strategies o Diagnostic strategies o Treatment strategies  Drugs, devices, non-pharmaceuticals
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_disposition-comments.pdf
    March 01, 2012 - For drugs like etidronate and sodium fluoride that could produce abnormal bone (osteomalacia) fracture … Based on a new RCT, we have added Teriparatide to the conclusion about drugs that effectively prevent … Yet these drugs are not included in the efficacy section. Delete. … These drugs have been omitted from the evidence table as they were deleted from the report. … A review of studies examining the characteristics of the drugs was beyond the scope of this project.
  18. effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
    January 01, 2007 - conduct and support research on the comparative outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … currently used interventions, including angioplasty with stent placement and/or those antihypertensive drugs … explicitly evaluated aggressive medical treatment with ACE inhibitors, statins, and anti-platelet drugs … after revascularization do occur in a small percentage of patients, and each of the antihypertensive drugs … eligibility criteria reported analyses of whether periprocedural interventions, such as different drugs
  19. effectivehealthcare.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
    January 01, 2009 - Medicare Parts A, B, and D Beneficiaries With Hypertension, With Use of One or More Antihypertensive Drugs … , With Hypertension and Use of One or More Antihypertensive Drugs, and Average Number of Antihypertensive … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypertensive Drugs … Medicare Parts A, B, and D Beneficiaries With Hypertension and Use of One or More Antihypretensive Drugs
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
    January 01, 2013 - Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … • Include information on the FDA status, indications, and relevant warnings for drugs or devices to … Disease-Modifying Antirheumatic Drugs (DMARDs) in Children With Juvenile Idiopathic Arthritis (JIA) … PICO (Intervention): Corticosteroids; Synthetic disease- modifying anti- rheumatic drugs (DMARDs)

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: